181 related articles for article (PubMed ID: 31417563)
41. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
[TBL] [Abstract][Full Text] [Related]
42. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Seldon PM; Barnes PJ; Meja K; Giembycz MA
Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
[TBL] [Abstract][Full Text] [Related]
43. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
[TBL] [Abstract][Full Text] [Related]
44. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
Villarreal DO; L'Huillier A; Armington S; Mottershead C; Filippova EV; Coder BD; Petit RG; Princiotta MF
Cancer Res; 2018 Sep; 78(18):5340-5348. PubMed ID: 30026324
[TBL] [Abstract][Full Text] [Related]
45. Prostaglandin E2 negatively regulates the production of inflammatory cytokines/chemokines and IL-17 in visceral leishmaniasis.
Saha A; Biswas A; Srivastav S; Mukherjee M; Das PK; Ukil A
J Immunol; 2014 Sep; 193(5):2330-9. PubMed ID: 25049356
[TBL] [Abstract][Full Text] [Related]
46. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
47. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
[TBL] [Abstract][Full Text] [Related]
48. Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes.
Nokta MA; Hassan MI; Loesch K; Pollard RB
J Clin Invest; 1996 Jun; 97(11):2635-41. PubMed ID: 8647958
[TBL] [Abstract][Full Text] [Related]
49. Changes in NMDA receptor-induced cyclic nucleotide synthesis regulate the age-dependent increase in PDE4A expression in primary cortical cultures.
Hajjhussein H; Suvarna NU; Gremillion C; Chandler LJ; O'Donnell JM
Brain Res; 2007 May; 1149():58-68. PubMed ID: 17407767
[TBL] [Abstract][Full Text] [Related]
50. Prostaglandin E2 promotes features of replicative senescence in chronically activated human CD8+ T cells.
Chou JP; Ramirez CM; Ryba DM; Koduri MP; Effros RB
PLoS One; 2014; 9(6):e99432. PubMed ID: 24918932
[TBL] [Abstract][Full Text] [Related]
51. Intrathecal injection of phosphodiesterase 4B-specific siRNA attenuates neuropathic pain in rats with L5 spinal nerve ligation.
Ji Q; Di Y; He X; Liu Q; Liu J; Li W; Zhang L
Mol Med Rep; 2016 Feb; 13(2):1914-22. PubMed ID: 26706904
[TBL] [Abstract][Full Text] [Related]
52. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
53. Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes.
Nazimek K; Ptak W; Nowak B; Ptak M; Askenase PW; Bryniarski K
Immunology; 2015 Sep; 146(1):23-32. PubMed ID: 25808106
[TBL] [Abstract][Full Text] [Related]
54. Role for the cAMP-protein kinase A signaling pathway in suppression of antitumor immune responses by regulatory T cells.
Yaqub S; Taskén K
Crit Rev Oncog; 2008; 14(1):57-77. PubMed ID: 19105570
[TBL] [Abstract][Full Text] [Related]
55. Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism.
Saha B; Mondal AC; Majumder J; Basu S; Dasgupta PS
Neuroimmunomodulation; 2001; 9(1):23-33. PubMed ID: 11435749
[TBL] [Abstract][Full Text] [Related]
56. Dimethyl fumarate activates the prostaglandin EP2 receptor and stimulates cAMP signaling in human peripheral blood mononuclear cells.
Fiedler SE; Kerns AR; Tsang C; Tsang V; Bourdette D; Salinthone S
Biochem Biophys Res Commun; 2016 Jun; 475(1):19-24. PubMed ID: 27157139
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
58. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
Manning CD; Burman M; Christensen SB; Cieslinski LB; Essayan DM; Grous M; Torphy TJ; Barnette MS
Br J Pharmacol; 1999 Dec; 128(7):1393-8. PubMed ID: 10602317
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
60. Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells.
Banner KH; Hoult JR; Taylor MN; Landells LJ; Page CP
Biochem Pharmacol; 1999 Nov; 58(9):1487-95. PubMed ID: 10513992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]